{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:20:32Z","timestamp":1783084832260,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12258-z","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:48:36Z","timestamp":1783082916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel homozygous C15ORF41 variant (c.251T\u2009>\u2009A; p.Val84Glu) causing congenital dyserythropoietic anemia type Ib in an Indian patient: molecular and structural evidence"],"prefix":"10.1007","volume":"53","author":[{"given":"Prachi","family":"Kamble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Dongerdiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejashree","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arati","family":"Saptarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Warang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-2913","authenticated-orcid":false,"given":"Prabhakar S.","family":"Kedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"3","key":"12258_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/17474086.2016.1131608","volume":"9","author":"A Gambale","year":"2016","unstructured":"Gambale A, Iolascon A, Andolfo I, Russo R (2016) Diagnosis and management of congenital dyserythropoietic anemias. Expert Rev Hematol 9(3):283\u2013296. https:\/\/doi.org\/10.1586\/17474086.2016.1131608","journal-title":"Expert Rev Hematol"},{"issue":"10","key":"12258_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00277-004-0892-5","volume":"83","author":"H Heimpel","year":"2004","unstructured":"Heimpel H (2004) Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis. Ann Hematol 83(10):613\u2013621. https:\/\/doi.org\/10.1007\/s00277-004-0892-5","journal-title":"Ann Hematol"},{"issue":"3","key":"12258_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MOH.0b013e32834521b0","volume":"18","author":"A Iolascon","year":"2011","unstructured":"Iolascon A, Russo R, Delaunay J (2011) Congenital dyserythropoietic anemias. Curr Opin Hematol 18(3):146\u2013151. https:\/\/doi.org\/10.1097\/MOH.0b013e32834521b0","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"12258_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2141.2005.05757.x","volume":"131","author":"SN Wickramasinghe","year":"2005","unstructured":"Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 131(4):431\u2013446. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05757.x","journal-title":"Br J Haematol"},{"key":"12258_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00277-020-04319-5","volume":"100","author":"M M\u00e9ndez","year":"2021","unstructured":"M\u00e9ndez M, Moreno-Carralero MI, Peri VL et al (2021) Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene. Ann Hematol 100:353\u2013364. https:\/\/doi.org\/10.1007\/s00277-020-04319-5","journal-title":"Ann Hematol"},{"issue":"3","key":"12258_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/jmedgenet-2020-106880","volume":"58","author":"AA Olijnik","year":"2021","unstructured":"Olijnik AA, Roy NBA, Scott C et al (2021) Genetic and functional insights into CDA-I prevalence and pathogenesis. J Med Genet 58(3):185\u2013195. https:\/\/doi.org\/10.1136\/jmedgenet-2020-106880","journal-title":"J Med Genet"},{"issue":"3","key":"12258_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/bjh.15817","volume":"185","author":"NBA Roy","year":"2019","unstructured":"Roy NBA, Babbs C (2019) The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I. Br J Haematol 185(3):436\u2013449. https:\/\/doi.org\/10.1111\/bjh.15817","journal-title":"Br J Haematol"},{"issue":"8","key":"12258_CR8","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/emboj.2012.55","volume":"31","author":"K Ask","year":"2012","unstructured":"Ask K, Jasencakova Z, Menard P, Feng Y, Almouzni G, Groth A (2012) Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply. EMBO J 31(8):2013\u20132023. https:\/\/doi.org\/10.1038\/emboj.2012.55","journal-title":"EMBO J"},{"key":"12258_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/msb4100134","volume":"3","author":"RM Ewing","year":"2007","unstructured":"Ewing RM, Chu P, Elisma F et al (2007) Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3:89. https:\/\/doi.org\/10.1038\/msb4100134","journal-title":"Mol Syst Biol"},{"issue":"11","key":"12258_CR10","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3324\/haematol.2020.260158","volume":"106","author":"C Scott","year":"2021","unstructured":"Scott C, Downes DJ, Brown JM et al (2021) Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities. Haematologica 106(11):2960\u20132970. https:\/\/doi.org\/10.3324\/haematol.2020.260158","journal-title":"Haematologica"},{"issue":"6","key":"12258_CR11","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1097\/HS9.0000000000000739","volume":"6","author":"NBA Roy","year":"2022","unstructured":"Roy NBA, Da Costa L, Russo R et al (2022) The use of next-generation sequencing in the diagnosis of rare inherited anaemias: a joint BSH\/EHA good practice paper. Hemasphere 6(6):e739. https:\/\/doi.org\/10.1097\/HS9.0000000000000739","journal-title":"Hemasphere"},{"issue":"9","key":"12258_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3324\/haematol.2013.089490","volume":"98","author":"C Babbs","year":"2013","unstructured":"Babbs C, Roberts NA, Sanchez-Pulido L et al (2013) Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. Haematologica 98(9):1383\u20131387. https:\/\/doi.org\/10.3324\/haematol.2013.089490","journal-title":"Haematologica"},{"issue":"5","key":"12258_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of ACMG and AMP. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"8","key":"12258_CR14","doi-asserted-by":"publisher","first-page":"E213","DOI":"10.1002\/ajh.25157","volume":"93","author":"J Palmblad","year":"2018","unstructured":"Palmblad J, Sander B, Bain B, Klimkowska M, Bj\u00f6rck E (2018) Congenital dyserythropoietic anemia type 1: a case with novel compound heterozygous mutations in the C15orf41 gene. Am J Hematol 93(8):E213\u2013E215. https:\/\/doi.org\/10.1002\/ajh.25157","journal-title":"Am J Hematol"},{"key":"12258_CR15","first-page":"921","volume":"92","author":"C Babbs","year":"2013","unstructured":"Babbs C, Roberts NA, Sanchez-Pulido L et al (2013) CDIN1 (C15ORF41) mutations cause congenital dyserythropoietic anemia type I. Am J Hum Genet 92:921\u2013927","journal-title":"Am J Hum Genet"},{"key":"12258_CR16","first-page":"153","volume":"87","author":"H Heimpel","year":"2008","unstructured":"Heimpel H, Wendt F (2008) Congenital dyserythropoietic anemia: epidemiology, clinical features, and treatment. Ann Hematol 87:153\u2013161","journal-title":"Ann Hematol"},{"key":"12258_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fphys.2019.00621","volume":"10","author":"R Russo","year":"2019","unstructured":"Russo R, Marra R, Andolfo I et al (2019) Characterization of two cases of congenital dyserythropoietic anemia type I sheds light on the uncharacterized C15orf41 protein. Front Physiol 10:621. https:\/\/doi.org\/10.3389\/fphys.2019.00621","journal-title":"Front Physiol"},{"key":"12258_CR18","first-page":"92","volume":"2017","author":"H Tamary","year":"2017","unstructured":"Tamary H, Dgany O (2017) Congenital dyserythropoietic anemia type I: molecular pathogenesis and clinical spectrum. Hematol Am Soc Hematol Educ Program 2017:92\u201398","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"12258_CR19","first-page":"23","volume":"1","author":"R Colah","year":"2015","unstructured":"Colah R, Mukherjee M, Martin S, Ghosh K (2015) Sickle cell disease in India: a systematic review and future directions. Pediatr Hematol Oncol J 1:23\u201329","journal-title":"Pediatr Hematol Oncol J"},{"issue":"1","key":"12258_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s10238-025-01785-x","volume":"25","author":"TW Yang","year":"2025","unstructured":"Yang TW, Tsai XC, Fu YH, Lin LI, Hou HA (2025) Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings. Clin Exp Med 25(1):242. https:\/\/doi.org\/10.1007\/s10238-025-01785-x","journal-title":"Clin Exp Med"},{"key":"12258_CR21","doi-asserted-by":"crossref","first-page":"100714","DOI":"10.1016\/j.blre.2020.100714","volume":"42","author":"R Kralovics","year":"2020","unstructured":"Kralovics R, Prchal JT (2020) Interferon therapy and emerging targeted treatments for congenital dyserythropoietic anemia. Blood Rev 42:100714","journal-title":"Blood Rev"},{"key":"12258_CR22","doi-asserted-by":"publisher","unstructured":"Kaplanis J, Samocha KE, Wiel L, et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature. 2020;586(7831):757-762. https:\/\/doi.org\/10.1038\/s41586-020-2832-5","DOI":"10.1038\/s41586-020-2832-5"},{"key":"12258_CR23","doi-asserted-by":"publisher","unstructured":"Zhou X, Feliciano P, Shu C, et al. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nat Genet. 2022;54(9):1305-1319. https:\/\/doi.org\/10.1038\/s41588-022-01148-2","DOI":"10.1038\/s41588-022-01148-2"},{"key":"12258_CR24","doi-asserted-by":"publisher","unstructured":"Marra R, Nostroso A, Rosato BE, et al. Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients. Am J Hematol. 2024;99(8):1511-1522. https:\/\/doi.org\/10.1002\/ajh.27350","DOI":"10.1002\/ajh.27350"},{"key":"12258_CR25","doi-asserted-by":"publisher","unstructured":"Kars ME, Ba\u015fak AN, Onat OE, et al. The genetic structure of the Turkish population reveals high levels of variation and admixture. Proc Natl Acad Sci U S A. 2021;118(36):e2026076118. https:\/\/doi.org\/10.1073\/pnas.2026076118","DOI":"10.1073\/pnas.2026076118"},{"key":"12258_CR26","doi-asserted-by":"publisher","unstructured":"Wang Y, Ru Y, Liu G, et al. Identification of CDAN1, C15ORF41 and SEC23B mutations in Chinese patients affected by congenital dyserythropoietic anemia. Gene. 2018;640:73-78. https:\/\/doi.org\/10.1016\/j.gene.2017.10.027","DOI":"10.1016\/j.gene.2017.10.027"},{"key":"12258_CR27","doi-asserted-by":"publisher","unstructured":"Russo R, Andolfo I, Manna F, et al. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018;93(5):672-682. https:\/\/doi.org\/10.1002\/ajh.25058","DOI":"10.1002\/ajh.25058"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12258-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:48:38Z","timestamp":1783082918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12258"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12258-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of the ICMR\u2013National Institute of Immunohematology, Mumbai, India. Written informed consent was obtained from the parents of the patient prior to enrolment in the study and for the publication of clinical and molecular data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"1093"}}